克服儿童中枢神经系统肿瘤尸检采集项目障碍:呼吁建立区域中心
本研究在辛辛那提儿童医院建立前瞻性儿童脑肿瘤库,制定教育、知情同意与组织处理流程。129例死亡患儿中109例符合条件,74%被接触,68%同意;最后一年接触与同意率分别达93%和85%。中位尸检间隔10小时,同意时间>24小时可降低间隔。
要点
- 儿童CNS肿瘤尸检采集可行,区域中心、严格同意时机与专职人员可缩短尸检间隔。
- 最后一年接触率93%、同意率85%,中位尸检间隔10小时(范围1.5-30)。
- 死亡前>24小时获取同意者尸检间隔更低,门诊距离增加则间隔延长。
核心结论
- 尸检标本采集不必成为神经肿瘤研究的障碍,区域中心、严格同意时机、患者教育与专职人员可缩短尸检间隔并提升组织价值。
研究设计与样本
- 前瞻性儿童脑肿瘤库研究,在辛辛那提儿童医院医学中心建立方案与基础设施,纳入2013至2018年死亡的129例儿童CNS肿瘤患者。
主要发现
- 129例死亡患儿中109例符合条件,74%(81/109)被接触,68%(55/81)同意。
- 研究最后一年接触率为93%,同意率为85%。
- 中位死亡至尸检间隔(PMI)为10小时(范围1.5-30)。
- 门诊设置中PMI随死亡地点至CCHMC距离增加而延长。
- 所有患者中,死亡前>24小时获取同意者PMI似乎更低。
临床怎么用
- 建立区域尸检采集中心,制定标准化教育、知情同意与组织运输流程。
- 尽早(死亡前>24小时)获取同意以缩短PMI,并考虑死亡地点距离对PMI的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While autopsy-repository programs with a variety of pediatric central nervous system (CNS) tumor types are a critical resource for preclinical neuro-oncology research, few exist and there is no published guidance on how to develop one. The goal of this prospective Pediatric Brain Tumor Repository (PBTR) study was to develop such a program at Cincinnati Children's Hospital Medical Center (CCHMC) and then publish the quantitative and experiential data as a guide to support the development of similar programs. METHODS: Protocols and infrastructure were established-to educate oncologists and families, establish eligibility, obtain consent, address pre- and post-autopsy logistics (e.g., patient and tissue transportation), process and authenticate tissue samples, and collect and analyze data. RESULTS: Of the 129 pediatric CNS tumor patients at CCHMC who died between 2013 and 2018, 109 were eligible for our study. Of these, 74% (81 of 109) were approached for PBTR donation, and 68% (55 of 81) consented. In the final year of the study, approach and consent rates were 93% and 85%, respectively. Median time from death to autopsy (postmortem interval, PMI) was 10 h (range, 1.5-30). In the outpatient setting, PMI increased with distance (from the hospice/home where the patient died to CCHMC). In all patients, PMI appeared to be lower, when consent was obtained more than 24 h before death. CONCLUSIONS: Procurement of autopsy specimens need not be a barrier in neuro-oncology research. Regional centers, strict timing-of-consent, patient education, and dedicated staff are all needed to minimize PMI and, thereby, increase the value of the procured tissue for an array of basic and translational research applications.
引用
- DeWire M, Erker C, Hummel TR, et al. Overcoming barriers to establishing autopsy procurement programs in pediatric patients with central nervous system tumors: a call to develop regional centers. J Neurooncol. 2021. PMID: 33502679. doi:10.1007/s11060-020-03679-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。